首页 | 本学科首页   官方微博 | 高级检索  
检索        

拉米夫定阻断乙型肝炎病毒在母婴传播的临床研究
引用本文:李永华,莫慧琼,王文凤,廖小清.拉米夫定阻断乙型肝炎病毒在母婴传播的临床研究[J].齐齐哈尔医学院学报,2012,33(2):207-208.
作者姓名:李永华  莫慧琼  王文凤  廖小清
作者单位:李永华 (广东省电白县人民医院,525400) ; 莫慧琼 (广东省电白县人民医院,525400) ; 王文凤 (广东省电白县人民医院,525400) ; 廖小清 (广东省电白县人民医院,525400) ;
摘    要:目的探讨妊娠晚期应用拉米夫定对乙型肝炎病毒(HBV)DNA载量孕妇HBV垂直传播的阻断作用。方法将60例孕妇随机分为两组。对照组用乙型肝炎免疫球蛋白(HBIG)治疗,观察组给予拉米夫定治疗。分别检测孕妇和新生儿的各项指标。结果观察组孕妇分娩前HBV-DNA显著降低(P<0.05),新生儿出生24h内HBsAg和HBV-DNA阳性率显著低于对照组(P<0.05);观察组新生儿出生后6个月和1岁时HBsAb阳性率显著高于对照组(P<0.05)。结论于妊娠晚期应用拉米夫定可显著降低孕妇HBV-DNA载量,阻断HBV的母婴传播,安全有效。

关 键 词:拉米夫定  乙型肝炎病毒  母婴传播

Clinical research on the blocking effect of lamivudine on HBV propagating in pregnant women
Institution:LI Yong-hua,et al.(Dianbai People’s Hospital,Maoming,Guangdong 525400,the P.R.China)
Abstract:Objective To evaluate the blocking effect of lamivudine on HBV propagating in pregnant women.Methods 60 cases of gravidas were divided into two groups.Gravidas in control group were treated by HBIG and observation group by lamivudine.The index for gravidas and neonatus were evaluated.Results HBV-DNA value in observation group at ante partum was lower than control group(P<0.05).The positive rates of HBsAg and HBV-DNA for within 24h postpartum were lower than control group(P<0.05).The positive rates of HBsAb for neonatus in observation group 6 months and 1 year postpartum were higher than control group(P<0.05).Conclusions Treating the gravidas by lamivudine at late trimester of pregnancy can reduce the capacity of HBV-DNA and block the propagating.It is safe and effective.
Keywords:Lamivudine HBV Propagating in pregnant women
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号